TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Hologic, Inc. (NASDAQ:HOLX) Investor Filed Lawsuit Against Carl C. Icahn And Others To Recover Alleged Short Swing Insider Trading Profits

  • If you purchased shares of Hologic, Inc. (NASDAQ:HOLX) and currently hold any of those NASDAQ:HOLX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Company
Hologic, Inc.
Security
NASDAQ: HOLX

Case Name
Hologic Shareholder Derivative Lawsuit 04/02/2015
Type of Lawsuit
Stockholder Derivative Action
You must register or login to receive notifications.

Click here to subscribe to Hologic, Inc..
Summary

April 6, 2015 (Shareholders Foundation) - An investor in shares of Hologic, Inc. (NASDAQ:HOLX) filed a lawsuit against Carl C. Icahn and others to recover short swing insider trading profits..
The plaintiff claims that the defendants are required to disgorge any profits they earn through short-swing insider trading when they are statutory insiders.

In late November 2013 activist investor Carl Icahn disclosed a 12.5% stake in Hologic, Inc..
Subsequently, Hologic, Inc. adopted a poison pill to prevent a hostile takeover.

Hologic, Inc. reported that its Total Revenue rose from over $2.49 billion for the 12 months period that ended on Sept. 28, 2013 to over $2.53 billion for the 12 months period that ended on Sept. 27, 2014 and that its Net Loss of over $1.17 billion for the 12 months period that ended on Sept. 28, 2013 turned into a Net Income of $17.30 million for the 12 months period that ended on Sept. 27, 2014.

Shares of Hologic, Inc. (NASDAQ:HOLX) grew from $19.08 per share in November 2012 to as high as $33.34 per share on March 31, 2015.